Long-term clinical outcomes in chronic hepatitis B patients with clearance of serum HBsAg

Li WANG,Cheng XU,Shi-qi TAO,Yu-ming WANG

DOI: https://doi.org/10.3969/j.issn.1008-1704.2015.05.008

2015-01-01

Abstract:Objective To investigate the long-term clinical features and outcomes of serum HBsAg loss in chronic hepatitis B patien.Methods Eighty-four patients diagnosed as chronic hepatitis B in Southwest hospital had experienced HBsAg seroclearance, among which 53 patients were through long-term antiviral therapy and 31 patients showed spontaneous HBsAg sreoclearance.Serum markers,liver biochemistry,and development of clinical complications were monitored during follow-up time.HBsAg and HBV DNA cumulative reappearance ratio,anti-HBs cumulative positive ratio were performed by Kaplan-Meier analysis,and the risk factors affecting the outcomes were analyzed by logistic regression analysis.Results Among a total of 84 patients with clearance of serum HBsAg,some patients reappeared to be HBsAg positive at the median 24 months (6-60 months)of follow-up.In the two groups,cumulative reappearance of HBsAg were 17% and 6.2%,respectively (P =0.093),and cumulative developing anti-HBs were 60.4% and 87.1 % respectively after HBsAg sreoclearance (P =0.024).Logistic regression analysis confirmed age as a key role in the development of anti-HBs (OR=0.925,P =0.006).After HBsAg seroclearanve,serum HBV-DNA of 18/59 patients were detectable by COBAS TaqMan48.At the end of follow-up,1 patients from antiviral therapy group developed HCC,3 patients developed cirrhosis in spontaneous HBsAg seroclearance group.Conclusion In chronic hepatitis B patients with serum HBsAg clearance following antiviral therapy or spontaneous seroclearance,most patients could achieve persistent HBsAg and HBV DNA negative.However,a small percentage of patients might reappear to be HBsAg and HBV DNA positive,even progress to cirrhosis or hepatocarcinoma.